Seroprevalence of SARS-CoV-2–Specific Antibodies: Faroe Islands

Maria Skaalum Petersen; Marin Strøm; Debes Hammershaimb Christiansen; Jógvan Páll Fjallsbak; Eina Eliasen; Malan Johansen; Anna Sofía Veyhe; Marnar Fríðheim Kristiansen; Shahin Gaini; Lars Fodgaard Møller; Bjarni á Steig; Pál Weihe

doi:10.3201/eid2611.202736

Seroprevalence of SARS-CoV-2–Specific Antibodies: Faroe Islands

Maria Skaalum Petersen, Marin Strøm, Debes Hammershaimb Christiansen, Jógvan Páll Fjallsbak, Eina Eliasen, Malan Johansen, Anna Sofía Veyhe, Marnar Fríðheim Kristiansen, Shahin Gaini, Lars Fodgaard Møller, Bjarni á Steig, Pál Weihe

Research output: Contribution to journal › Article › peer-review

26 Citations (Scopus)

Abstract

We conducted a nationwide study of the prevalence of severe acute respiratory syndrome coronavirus 2 infection in the Faroe Islands. Of 1,075 randomly selected participants, 6 (0.6%) tested seropositive for antibodies to the virus. Adjustment for test sensitivity and specificity yielded a 0.7% prevalence. Our findings will help us evaluate our public health response.

Original language	English
Pages (from-to)	2760-2762
Number of pages	3
Journal	Emerging Infectious Diseases
Volume	26
Issue number	11
DOIs	https://doi.org/10.3201/eid2611.202736
Publication status	Published - Nov 2020

Keywords

SARS-CoV-2
antibodies
Faroe Islands

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3201/eid2611.202736

Cite this

@article{3849e6c16bcf4013a0b953f0f0c0e434,

title = "Seroprevalence of SARS-CoV-2–Specific Antibodies: Faroe Islands",

abstract = "We conducted a nationwide study of the prevalence of severe acute respiratory syndrome coronavirus 2 infection in the Faroe Islands. Of 1,075 randomly selected participants, 6 (0.6%) tested seropositive for antibodies to the virus. Adjustment for test sensitivity and specificity yielded a 0.7% prevalence. Our findings will help us evaluate our public health response.",

keywords = "SARS-CoV-2, antibodies, Faroe Islands",

author = "Petersen, {Maria Skaalum} and Marin Str{\o}m and Christiansen, {Debes Hammershaimb} and Fjallsbak, {J{\'o}gvan P{\'a}ll} and Eina Eliasen and Malan Johansen and Veyhe, {Anna Sof{\'i}a} and Kristiansen, {Marnar Fr{\'i}{\dh}heim} and Shahin Gaini and M{\o}ller, {Lars Fodgaard} and Steig, {Bjarni {\'a}} and P{\'a}l Weihe",

note = "Research Letter",

year = "2020",

month = nov,

doi = "10.3201/eid2611.202736",

language = "English",

volume = "26",

pages = "2760--2762",

journal = "Emerging Infectious Diseases",

issn = "1080-6040",

publisher = "Centers for Disease Control and Prevention (CDC)",

number = "11",

}

TY - JOUR

T1 - Seroprevalence of SARS-CoV-2–Specific Antibodies

T2 - Faroe Islands

AU - Petersen, Maria Skaalum

AU - Strøm, Marin

AU - Christiansen, Debes Hammershaimb

AU - Fjallsbak, Jógvan Páll

AU - Eliasen, Eina

AU - Johansen, Malan

AU - Veyhe, Anna Sofía

AU - Kristiansen, Marnar Fríðheim

AU - Gaini, Shahin

AU - Møller, Lars Fodgaard

AU - Steig, Bjarni á

AU - Weihe, Pál

N1 - Research Letter

PY - 2020/11

Y1 - 2020/11

N2 - We conducted a nationwide study of the prevalence of severe acute respiratory syndrome coronavirus 2 infection in the Faroe Islands. Of 1,075 randomly selected participants, 6 (0.6%) tested seropositive for antibodies to the virus. Adjustment for test sensitivity and specificity yielded a 0.7% prevalence. Our findings will help us evaluate our public health response.

AB - We conducted a nationwide study of the prevalence of severe acute respiratory syndrome coronavirus 2 infection in the Faroe Islands. Of 1,075 randomly selected participants, 6 (0.6%) tested seropositive for antibodies to the virus. Adjustment for test sensitivity and specificity yielded a 0.7% prevalence. Our findings will help us evaluate our public health response.

KW - SARS-CoV-2

KW - antibodies

KW - Faroe Islands

UR - http://dx.doi.org/10.3201/eid2611.202736

U2 - 10.3201/eid2611.202736

DO - 10.3201/eid2611.202736

M3 - Article

SN - 1080-6040

VL - 26

SP - 2760

EP - 2762

JO - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

IS - 11

ER -

Seroprevalence of SARS-CoV-2–Specific Antibodies: Faroe Islands

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Tracing the true prevalence of COVID-19 in the Faroe Islands: COVID-19 dark numbers in the Faroe Islands / Hvussu nógv fólk í Føroyum hava andevni í blóðinum móti koronavirusi?

Cite this

Seroprevalence of SARS-CoV-2–Specific Antibodies: Faroe Islands

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Projects

Tracing the true prevalence of COVID-19 in the Faroe Islands: COVID-19 dark numbers in the Faroe Islands / Hvussu nógv fólk í Føroyum hava andevni í blóðinum móti koronavirusi?

Cite this